Kim Kelderman
2018
In 2018, Kim Kelderman earned a total compensation of $1.2M as President, Diagnostics and Genomics at Bio-Techne.
Compensation breakdown
| Non-Equity Incentive Plan | $36,250 |
|---|---|
| Option Awards | $301,603 |
| Salary | $72,500 |
| Stock Awards | $753,900 |
| Other | $1,004 |
| Total | $1,165,256 |
Kelderman received $753.9K in stock awards, accounting for 65% of the total pay in 2018.
Kelderman also received $36.3K in non-equity incentive plan, $301.6K in option awards, $72.5K in salary and $1K in other compensation.
Rankings
In 2018, Kim Kelderman's compensation ranked 8,421st out of 14,244 executives tracked by ExecPay. In other words, Kelderman earned more than 40.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,421 out of 14,244 | 41st |
Division Manufacturing | 3,343 out of 5,758 | 42nd |
Major group Chemicals And Allied Products | 1,253 out of 2,119 | 41st |
Industry group Drugs | 1,046 out of 1,808 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 197 out of 339 | 42nd |
Source: SEC filing on September 9, 2019.
Kelderman's colleagues
We found four more compensation records of executives who worked with Kim Kelderman at Bio-Techne in 2018.